Table 2.
Phenotypic correlations | Cross-twin cross-trait correlations (95%CI) | Twin model estimates (95% CI)a | |||
---|---|---|---|---|---|
rMZ | rDZ | ra | re | ||
IBD and asthma | 0.05 (0.01 to 0.09) | 0.06 (−0.02 to 0.14) | −0.06 (−0.12 to 0.00) | 0.05 (−0.03 to 0.12) | 0.08 (−0.10 to 0.27) |
IBD and allergic rhinitis | 0.07 (0.03 to 0.11) | 0.04 (−0.03 to 0.11) | 0.02 (−0.03 to 0.06) | 0.06 (−0.03 to 0.15) | 0.12 (−0.04 to 0.29) |
IBD and eczema | 0.11 (0.07 to 0.15) | 0.09 (0.01 to 0.17) | −0.03 (−0.09 to 0.02) | 0.06 (−0.05 to 0.17) | 0.16 (0.00 to 0.32) |
Abbreviations: a, additive genetic component; CI, confidence interval; e, nonshared environmental component (including measurement errors); IBD, inflammatory bowel disease.
aAll models were adjusted for sex and birth year (continuous, standardized).